CONTROLLED RELEASE SALBUTAMOL TABLETS VERSUS SUSTAINED-RELEASE THEOPHYLLINE TABLETS IN THE CONTROL OF REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE

被引：6

作者：

VYSE, T ^{[1
]}

COCHRANE, GM ^{[1
]}

机构：

[1] GUYS HOSP,DEPT THORAC MED,ST THOMAS ST,LONDON SE1 9RT,ENGLAND

来源：

关键词：

D O I：

10.1177/030006058901700114

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：93 / 98

页数：6

共 12 条

[1] BARNES PJ, 1982, LANCET, V1, P299
[2] DAHL R, 1988, EUR RESPIR J, V1, pS206
[3] HERRMANN G, 1937, J LAB CLIN MED, V23, P135
[4] 2-PERIOD CROSSOVER CLINICAL-TRIAL
HILLS, M
ARMITAGE, P
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) : 7 - 20
[5] HORN CR, 1984, LANCET, V1, P1143
[6] JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349
[7] COMPARISON OF A CONTROLLED-RELEASE TABLET OF SALBUTAMOL GIVEN TWICE DAILY WITH A STANDARD TABLET GIVEN 4 TIMES DAILY IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE LUNG-DISEASE
MAESEN, FPV
SMEETS, JJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) : 431 - 436
[8] RALL TW, 1985, PHARMACOL BASIS THER, P589
[9] SYKES RS, 1987, J ALLERGY CLIN IMMUN, V79, P152
[10] VOZEH S, 1982, AM REV RESPIR DIS, V125, P181